Inventor · disambiguated record
Jonathan Schneck
Also filed as: SCHNECK JONATHAN · SCHNECK JONATHAN P
15 granted patents·16 pending applications·327 citations·filing 1997–2023
93Inventor score
Top patents by PatentIndex Score
31 records- 0191US6015884ASoluble divalent and multivalent heterodimeric analogs of proteinsUNIV JOHNS HOPKINS·Filed 1997·Granted Jan 18, 2000·80 cites·10 claims
- 0290US6268411B1Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responsesUNIV JOHNS HOPKINS·Filed 1998·Granted Jul 31, 2001·95 cites·104 claims
- 0389US10098939B2Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cellsUNIV JOHNS HOPKINS·Filed 2017·Granted Oct 16, 2018·5 cites·20 claims
- 0488US6734013B2Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responsesUNIV JOHNS HOPKINS·Filed 2001·Granted May 11, 2004·27 cites·4 claims
- 0587US6458354B1Molecular complexes which modify immune responsesUNIV JOHNS HOPKINS·Filed 2000·Granted Oct 1, 2002·28 cites·13 claims
- 0684US10987412B2Reagents and methods for identifying, enriching, and/or expanding antigen-specific T cellsUNIV JOHNS HOPKINS·Filed 2015·Granted Apr 27, 2021·3 cites·27 claims
- 0779US6448071B1Soluble divalent and multivalent heterodimeric analogs of proteinsUNIV JOHNS HOPKINS·Filed 1999·Granted Sep 10, 2002·35 cites·92 claims
- 0876US7973137B1Cell compositions comprising molecular complexes that modify immune responsesUNIV JOHNS HOPKINS·Filed 2000·Granted Jul 5, 2011·8 cites·15 claims
- 0974US6140113APolynucleotides encoding molecular complexes which modify immune responsesUNIV JOHNS HOPKINS·Filed 1998·Granted Oct 31, 2000·45 cites·12 claims
- 1068US11939595B2Nanoscale artificial antigen presenting cellsUNIV JOHNS HOPKINS·Filed 2019·Granted Mar 26, 2024·0 cites·16 claims
- 1168US10435668B2Nanoscale artificial antigen presenting cellsUNIV JOHNS HOPKINS·Filed 2014·Granted Oct 8, 2019·1 cites·15 claims
- 1265US2023332131A1Production of antigen-specific t-cellsNEXIMMUNE INC·Filed 2023·Application pending·0 cites
- 1364US2010008920A1Reagents and Methods for Engaging Unique Clonotypic Lymphocyte ReceptorsUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 1464US2025154225A1Mhc ii artificial antigen presenting cells harness the effector and helper functions of antigen-specific cd4+ t cellsUNIV JOHNS HOPKINS·Filed 2022·Application pending·0 cites
- 1563US11986538B2Immunoswitch nanoparticles for reprogrammed T cell responsesUNIV JOHNS HOPKINS·Filed 2021·Granted May 21, 2024·0 cites·18 claims
- 1663US2021252121A1Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cellsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1761US2004204565A1Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responsesUNIV JOHNS HOPKINS·Filed 2004·Application pending·0 cites
- 1859US2021046008A1Artificial antigen presenting cells having a defined and dynamic shapeUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 1958US10758487B2Artificial antigen presenting cells having a defined and dynamic shapeUNIV JOHNS HOPKINS·Filed 2012·Granted Sep 1, 2020·0 cites·18 claims
- 2056US2017261497A1Reagents and Methods for Engaging Unique Clonotypic Lymphocyte ReceptorsUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2154US2012141482A1Molecular complexes which modify immune responsesSCHNECK JONATHAN·Filed 2012·Application pending·0 cites
- 2253US2011243967A1Molecular complexes which modify immune responsesUNIV JOHNS HOPKINS·Filed 2011·Application pending·0 cites
- 2352US2023243825A1Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific t cellsUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2450US10463750B2Antigen-Specific T cell redirectorsUNIV JOHNS HOPKINS·Filed 2014·Granted Nov 5, 2019·0 cites·10 claims
- 2549US2020291381A1Production of antigen-specific t-cellsNEXIMMUNE INC·Filed 2017·Application pending·0 cites
- 2648US12059476B2Biodegradable biomimetic particlesUNIV JOHNS HOPKINS·Filed 2018·Granted Aug 13, 2024·0 cites·34 claims
- 2748US2002127231A1Soluble divalent and multivalent heterodimeric analogs of proteinsFiled 2001·Application pending·0 cites
- 2848US2004115216A1Reagents and methods for engaging unique clonotypic lymphocyte receptorsUNIV JOHNS HOPKINS·Filed 2003·Application pending·0 cites
- 2948US2022168442A1Artificial t-cell stimulating matrix for immunotherapyUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 3045US2011256147A1Diagnostic and treatment methods for cancer based on immune inhibitorsUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 3135US2011300168A1Compositions and methods for inducing an immune response against influenza antigensSCHNECK JONATHAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Schneck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →